Skip to content

Author

Chel-Hun Choi

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Baseline Systemic Inflammation Response Index and Clinical Outcomes in Heavily Pretreated Platinum-Resistant Ovarian Cancer Treated with Pembrolizumab Monotherapy

Simple Summary Platinum-resistant ovarian cancer is difficult to treat, and the immunotherapy drug pembrolizumab provides long-lasting cancer control in only a small proportion of patients. We investigated whether routine blood tests taken before treatment could provide information about which patients tend to have bet...

Seongyun Lim, Yurimi Lee, Heeeun Ha et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.